Wednesday, January 13, 2010

GeorgiaBio: Altea

GeorgiaBio: Altea & KAI Pharma Enter into a Preclinical and Clinical Development Agreement for the Transdermal Delivery of Certain Novel KAI Peptides

Posted using ShareThis

No comments:

Post a Comment